Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepivacaine for Tourniquet Associated Ischemic Hypertension in Total Ankle Arthroplasty
NCT04454203Phase 4Recruiting
- Sponsor
- Duke University
- Start
- Feb 2021
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mepivacaine in hypertension (HTN), sponsored by Duke University. Started Feb 2021; status: recruiting.
02
Drugs
mepivacaine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04454203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04454203.